Monoclonal antibody therapy
Monoclonal antibody therapy is a form of immunotherapy that uses monoclonal antibodies (mAb) to bind to specific cells or proteins. This may then stimulate the patient's immune system to attack those cells. It is possible to create a mAb that is specific for any given target. In this way, monoclonal antibody therapy is a way to specifically target disease-related cells.
History[edit | edit source]
The concept of monoclonal antibody therapy was first developed in the 1970s by César Milstein and Georges J. F. Köhler, who were later awarded the Nobel Prize in Physiology or Medicine for their work. The first therapeutic monoclonal antibody, muromonab-CD3, was approved in 1986 for the treatment of acute transplant rejection.
Mechanism of action[edit | edit source]
Monoclonal antibodies are designed to bind to antigens that are generally more numerous on the cell surface of cancer cells than healthy cells. The binding of the monoclonal antibody to the antigen can lead to an immune response that can destroy the cancer cell. The monoclonal antibodies can also be designed to block signals that allow cancer cells to grow and divide uncontrollably.
Uses[edit | edit source]
Monoclonal antibody therapy is currently used in the treatment of a variety of conditions, including different types of cancer, autoimmune diseases, and infectious diseases. For example, trastuzumab (Herceptin) is used in the treatment of certain types of breast cancer, and rituximab (Rituxan) is used in the treatment of certain types of lymphoma.
Side effects[edit | edit source]
Like all therapies, monoclonal antibody therapy can have side effects. These can include allergic reactions, skin rashes, flu-like symptoms, and more serious side effects such as heart problems and immune reactions.
Future directions[edit | edit source]
Research is ongoing to develop new monoclonal antibodies for the treatment of other diseases, to improve the efficacy of existing monoclonal antibody therapies, and to reduce side effects.
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
